Directory
>
Paris Panayiotopoulos
Paris Panayiotopoulos
Founder, Board Director | AvenCell
United States
Paris Panayiotopoulos
Summary
Paris Panayiotopoulos is a seasoned executive with extensive experience in the life sciences and pharmaceutical industries. Currently a Partner and member of the Investment Committee at Blackstone Life Sciences, he has a proven track record of founding and directing multiple successful ventures. His leadership roles span from CEO at Ariad Pharmaceuticals to Board Director positions at various biotech firms. Paris has a strong academic background with degrees in Chemistry and Marketing from prestigious institutions. His strategic vision and ability to navigate complex markets have made him a key player in the investment community. Paris is also known for his keen interest in innovation and emerging technologies within the healthcare sector, reflecting his commitment to driving advancements in life sciences. With a career marked by significant contributions to both startups and established companies, he embodies the spirit of entrepreneurship and leadership.
Paris Panayiotopoulos
Work Experience
Founder, Board Director at
AvenCell
October 2021 - Present
Founder, Board Director at
Anthos Therapeutics
February 2019 - Present
Senior Managing Director and Member of the Investment Committee - Blackstone Life Sciences at
Blackstone
December 2018 - Present
Founder, Chairman at
Genevant Sciences, Inc.
January 2018 - July 2020
Board Director (Sold to Novartis in 2020) at
Novartis
March 2017 - January 2020
Partner (Sold to Blackstone in 2018) at
Lifesciences I Clarus L P
March 2018 - December 2018
CEO, President and Member of the Board of Directors (Sold to Takeda in 2017) at
Takeda Pharmaceuticals America, Inc.
January 2016 - April 2017
President, North America, Merck KGaA at
EMD Serono, Inc.
November 2014 - December 2016
President, Japan, Merck KGaA at
MERCK ROMANIA SRL
July 2013 - November 2014
Chief of Staff to Healthcare CEO at
Merck KGaA, Darmstadt, Germany
December 2012 - July 2013
Head Western Europe, Endocrinogy & Fertility at
Merck KGaA, Darmstadt, Germany
December 2011 - December 2012
Global Neurology Strategy Director at
Merck KGaA, Darmstadt, Germany
September 2008 - December 2011
Strategy / Business Intelligence Director at
Serono International
June 2004 - September 2008
GM Leadership Program at
Eli Lilly and Company
June 2000 - June 2004
Associate Director at
Martin Hamblin Consultants
September 1997 - June 2000
Paris Panayiotopoulos
Education
Cranfield , Msc
January 1996 - January 1997
University College London, Bsc
January 1993 - January 1996
Frequently Asked Questions about Paris Panayiotopoulos
What is Paris Panayiotopoulos email address?
Paris Panayiotopoulos's primary email address is *********************@blackstone.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Paris Panayiotopoulos work for?
Paris Panayiotopoulos is a Founder, Board Director at AvenCell.
Where Paris Panayiotopoulos graduated from?
Paris Panayiotopoulos holds a degree in Marketing from Cranfield .
How can I directly contact Paris Panayiotopoulos?
To contact Paris Panayiotopoulos directly, you can use the email address *********************@blackstone.com. Complete contact information is available upon registration with Muraena.
Who is Paris Panayiotopoulos?
Paris Panayiotopoulos is a seasoned executive with extensive experience in the life sciences and pharmaceutical industries. Currently a Partner and member of the Investment Committee at Blackstone Life Sciences, he has a proven track record of founding and directing multiple successful ventures. His leadership roles span from CEO at Ariad Pharmaceuticals to Board Director positions at various biotech firms. Paris has a strong academic background with degrees in Chemistry and Marketing from prestigious institutions. His strategic vision and ability to navigate complex markets have made him a key player in the investment community. Paris is also known for his keen interest in innovation and emerging technologies within the healthcare sector, reflecting his commitment to driving advancements in life sciences. With a career marked by significant contributions to both startups and established companies, he embodies the spirit of entrepreneurship and leadership.
Paris`s contact details
*********************@blackstone.com
*********************@anthostherapeutics.com
Colleagues
Vice President Clinical Operations
VP, Head of US Research
Chief Executive Officer